Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity
Authors:
- Yiqiang WangYWYiqiang Wang
- Christina CherianCCChristina Cherian
- Zhanjun HouZHZhanjun Hou
- Steven A. BuckSBSteven A. Buck
- Larry H. MatherlyLMLarry H. Matherly
- Aleem GangjeeAGAleem Gangjee
- 1 August 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (16) , 5052-5063
Abstract
6-Substituted classical pyrrolo[2,3-d]pyrimidine antifolates with a three- to six-carbon bridge between the heterocycle and the benzoyl-l-glutamate (compounds 2−5, respectively) were synthesized starting from methyl 4-formylbenzoate and a Wittig reaction with the appropriate triphenylphosphonium bromide, followed by reduction and conversion to the α-bromomethylketones. Cyclocondensation of 2,4-diamino-4-oxopyrimidine with the α-bromoketones, coupling with diethyl-l-glutamate, and saponification afforded 2−5. Compounds 2−5 had negligible substrate activity for RFC but showed variably potent (nanomolar) and selective inhibitory activities toward Chinese hamster ovary cells that expressed FRα or FRβ and toward FRα-expressing KB and IGROV1 human tumor cells. Inhibition of KB cell colony formation was also observed. Glycinamide ribonucleotide formyl transferase (GARFTase) was identified as the primary intracellular target of the pyrrolo[2,3-d]pyrimidines. The combined properties of selective FR targeting, lack of RFC transport, and GARFTase inhibition resulting in potent antitumor activity are unprecedented and warrant development of these analogues as antitumor agents.Keywords
This publication has 37 references indexed in Scilit:
- Human reduced folate carrier: translation of basic biology to cancer etiology and therapyCancer and Metastasis Reviews, 2007
- The folate receptor: What does it promise in tissue-targeted therapeutics?Cancer and Metastasis Reviews, 2007
- Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate MalabsorptionCell, 2006
- BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing TumorsCancer Research, 2005
- Synthesis of Classical, Four-Carbon Bridged 5-Substituted Furo[2,3-d]pyrimidine and 6-Substituted Pyrrolo[2,3-d]pyrimidine Analogues as AntifolatesJournal of Medicinal Chemistry, 2005
- Lack of Impact of the Loss of Constitutive Folate Receptor α Expression, Achieved by RNA Interference, on the Activity of the New Generation Antifolate Pemetrexed in HeLa CellsClinical Cancer Research, 2004
- Resistance to antifolatesOncogene, 2003
- Molecular, biochemical, and cellular pharmacology of pemetrexedSeminars in Oncology, 2002
- Tight Binding of Folate Substrates and Inhibitors to Recombinant Mouse Glycinamide Ribonucleotide FormyltransferaseBiochemistry, 1997
- Studies on simplified ergoline derivatives. A general six-step synthesis of phenyl-substituted 4-methyl-3,4,4a,5,6,10b-hexahydrobenzo[f]quinolin-1-(2H)-one analogsJournal of Heterocyclic Chemistry, 1982